2007

Glycemic Control in Type 2 Diabetes: Clinical Trends and Controversies CME

Philip Levy, MD, MACE; John Sheehan, MD, FACE, FACN

Release Date: March 11, 2009

268 MMG(43,6% Tot.MMG ASL)

4639 DMT2(36,8% Tot.DMT2 noti)

1250

1300

1350

1400

1450

1500

1550

1600

1650

<=130/80

Basale 1 anno

DMT2 e HTA: 3099 (66,8%)

DMT2 in terapia:

2086/4639

(44,96%)